Compare ACIC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACIC | AUTL |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.5M | 431.2M |
| IPO Year | 2007 | 2025 |
| Metric | ACIC | AUTL |
|---|---|---|
| Price | $11.80 | $1.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 137.1K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.39% | N/A |
| EPS Growth | ★ 39.61 | N/A |
| EPS | ★ 2.15 | N/A |
| Revenue | ★ $335,439,000.00 | $10,120,000.00 |
| Revenue This Year | N/A | $84.74 |
| Revenue Next Year | $1.00 | $65.76 |
| P/E Ratio | $5.46 | ★ N/A |
| Revenue Growth | 13.07 | ★ 496.00 |
| 52 Week Low | $9.97 | $1.15 |
| 52 Week High | $13.06 | $2.70 |
| Indicator | ACIC | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 62.66 |
| Support Level | $11.53 | $1.25 |
| Resistance Level | $12.44 | $1.69 |
| Average True Range (ATR) | 0.27 | 0.09 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 93.02 | 98.74 |
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.